525 related articles for article (PubMed ID: 19386549)
1. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models.
Dupuis L; Loeffler JP
Curr Opin Pharmacol; 2009 Jun; 9(3):341-6. PubMed ID: 19386549
[TBL] [Abstract][Full Text] [Related]
2. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
[TBL] [Abstract][Full Text] [Related]
3. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Hegedus J; Putman CT; Gordon T
Neurobiol Dis; 2007 Nov; 28(2):154-64. PubMed ID: 17766128
[TBL] [Abstract][Full Text] [Related]
4. Dynamic neuromuscular remodeling precedes motor-unit loss in a mouse model of ALS.
Martineau É; Di Polo A; Vande Velde C; Robitaille R
Elife; 2018 Oct; 7():. PubMed ID: 30320556
[TBL] [Abstract][Full Text] [Related]
5. Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis.
Cappello V; Francolini M
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 28972545
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice.
Wong M; Martin LJ
Hum Mol Genet; 2010 Jun; 19(11):2284-302. PubMed ID: 20223753
[TBL] [Abstract][Full Text] [Related]
7. Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.
Verma S; Khurana S; Vats A; Sahu B; Ganguly NK; Chakraborti P; Gourie-Devi M; Taneja V
Mol Neurobiol; 2022 Mar; 59(3):1502-1527. PubMed ID: 34997540
[TBL] [Abstract][Full Text] [Related]
8. [Amyotrophic lateral sclerosis: role of energy deficiency in neuromuscular junction dismantlement].
Dupuis L; Loeffler JP
Med Sci (Paris); 2008 Dec; 24(12):1077-82. PubMed ID: 19116118
[TBL] [Abstract][Full Text] [Related]
9. Epothilone D accelerates disease progression in the SOD1
Clark JA; Blizzard CA; Breslin MC; Yeaman EJ; Lee KM; Chuckowree JA; Dickson TC
Neuropathol Appl Neurobiol; 2018 Oct; 44(6):590-605. PubMed ID: 29380402
[TBL] [Abstract][Full Text] [Related]
10. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis.
Rothstein JD
Ann Neurol; 2009 Jan; 65 Suppl 1():S3-9. PubMed ID: 19191304
[TBL] [Abstract][Full Text] [Related]
11. Motor unit number estimation predicts disease onset and survival in a transgenic mouse model of amyotrophic lateral sclerosis.
Shefner JM; Cudkowicz M; Brown RH
Muscle Nerve; 2006 Nov; 34(5):603-7. PubMed ID: 16892429
[TBL] [Abstract][Full Text] [Related]
12. Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.
Tremblay E; Martineau É; Robitaille R
J Neurosci; 2017 Sep; 37(37):8901-8918. PubMed ID: 28821658
[TBL] [Abstract][Full Text] [Related]
13. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
[TBL] [Abstract][Full Text] [Related]
14. Adipose-derived stem cell conditioned medium impacts asymptomatic peripheral neuromuscular denervation in the mutant superoxide dismutase (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
Walker CL; Meadows RM; Merfeld-Clauss S; Du Y; March KL; Jones KJ
Restor Neurol Neurosci; 2018; 36(5):621-627. PubMed ID: 30010155
[TBL] [Abstract][Full Text] [Related]
15. Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the
Martineau É; Arbour D; Vallée J; Robitaille R
J Neurosci; 2020 Sep; 40(40):7759-7777. PubMed ID: 32859714
[TBL] [Abstract][Full Text] [Related]
16. Neuromuscular effects of G93A-SOD1 expression in zebrafish.
Sakowski SA; Lunn JS; Busta AS; Oh SS; Zamora-Berridi G; Palmer M; Rosenberg AA; Philip SG; Dowling JJ; Feldman EL
Mol Neurodegener; 2012 Aug; 7():44. PubMed ID: 22938571
[TBL] [Abstract][Full Text] [Related]
17. Reduced VGLUT2 expression increases motor neuron viability in Sod1(G93A) mice.
Wootz H; Enjin A; Wallén-Mackenzie A; Lindholm D; Kullander K
Neurobiol Dis; 2010 Jan; 37(1):58-66. PubMed ID: 19770042
[TBL] [Abstract][Full Text] [Related]
18. Length-dependent axo-terminal degeneration at the neuromuscular synapses of type II muscle in SOD1 mice.
Tallon C; Russell KA; Sakhalkar S; Andrapallayal N; Farah MH
Neuroscience; 2016 Jan; 312():179-89. PubMed ID: 26592719
[TBL] [Abstract][Full Text] [Related]
19. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis.
Schaefer AM; Sanes JR; Lichtman JW
J Comp Neurol; 2005 Sep; 490(3):209-19. PubMed ID: 16082680
[TBL] [Abstract][Full Text] [Related]
20. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.
Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D
Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
